CRDF — Cardiff Oncology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Cardiff Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	131	141	105	74.8	91.7
Net Total Accounts Receivable
Net Total Receivables	0.32	0.535	0.771	0.888	1.17
Prepaid Expenses
Total Current Assets	133	146	111	77.4	95.1
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.967	3.18	3.52	2.95	2.07
Other Long Term Assets
Total Assets	135	150	116	81.6	97.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	6.12	6.56	7.81	10.4	13.4
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	6.57	9.13	9.85	11.9	14.2
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	128	140	106	69.7	82.9
Total Liabilities & Shareholders' Equity	135	150	116	81.6	97.2
Total Common Shares Outstanding
Total Preferred Shares Outstanding